1 paper
Dehua Bi, Katherine Ryan, Sabine Heitzeneder +6
We propose a novel Phase I intra-patient dose-escalation design tailored for multi-cycle immunotherapy settings, in which toxicity at a fixed dose level is clinically expected to d…